
Merck has paid out $688 million to end two class-action lawsuits which sprang up after the revelation of disappointing trial …
Vytorin has been shown to reduce potentially heart problems in patients with chronic kidney disease (CKD) in a new study. …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

